Evogene Financial Results for the Third Quarter of 2017 Earnings Announcement Schedule
02 November 2017 - 11:00PM
Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology
company developing novel products for life science markets through
the use of a unique computational predictive biology platform,
announced today that it will release its financial results for the
third quarter of 2017 on Wednesday, November 22, 2017.
On the day of the announcement, the Company’s
management will host a conference call to discuss the results at
09:00 AM Eastern time, 16:00 Israel time. To access the conference
call, please dial 1-888-281-1167 toll free from the United States,
or +972-3-918-0685 internationally. Access to the call will also be
available via live webcast through the Company’s website at
www.evogene.com.
A replay of the conference call will be
available approximately three hours following the completion of the
call. To access the replay, please dial 1-888-326-9310 toll free
from the United States, or +972-3-925-5927 internationally. The
replay will be accessible through November 24, 2017, and an archive
of the webcast will be available on the Company’s website through
December 4, 2017.
About Evogene Ltd.:
Evogene (NASDAQ:EVGN) (TASE:EVGN) is a leading
biotechnology company developing novel products for life science
markets through the use of a unique computational predictive
biology platform. The Company operates in three key target markets:
improved seed traits (addressing yield increase, tolerance to
environmental stresses and resistance to insects and diseases);
innovative ag-chemicals (developing novel herbicide solutions for
weed control); and ag-biologicals (developing microbiome based
ag-products). Evogene has collaborations with world-leading seed
and ag-chemical companies. For more information, please visit
www.evogene.com or contact the Company at info@evogene.com.
Forward Looking Statements:
This press release contains “forward-looking
statements” relating to future events. These statements may be
identified by words such as “may”, “could”, “expects”, "intends",
“anticipates”, “plans”, “believes”, “scheduled”, “estimates” or
words of similar meaning. Such statements are based on current
expectations, estimates, projections and assumptions, describe
opinions about future events, involve certain risks and
uncertainties which are difficult to predict and are not guarantees
of future performance. Therefore, actual future results,
performance or achievements of Evogene may differ materially from
what is expressed or implied by such forward-looking statements due
to a variety of factors, many of which beyond Evogene's control,
including, without limitation, those risk factors contained in
Evogene’s reports filed with the appropriate securities authority.
Evogene disclaims any obligation or commitment to update these
forward-looking statements to reflect future events or developments
or changes in expectations, estimates, projections and
assumptions.
Contact:
Nir ZalikIR/PR managerE: IR@evogene.comT:
(+972)-8-931-1963
Evogene (NASDAQ:EVGN)
Historical Stock Chart
From May 2024 to Jun 2024
Evogene (NASDAQ:EVGN)
Historical Stock Chart
From Jun 2023 to Jun 2024